Prognostic Value of Oxygen Kinetics During Recovery From Cardiopulmonary Exercise Testing in Patients With Chronic Heart Failure

Can J Cardiol. 2015 Oct;31(10):1259-65. doi: 10.1016/j.cjca.2015.02.015. Epub 2015 Feb 19.

Abstract

Background: Peak oxygen uptake (V˙O2peak) is a well-established prognostic marker in chronic heart failure (CHF). Cardiopulmonary exercise testing (CPET) provides physiological parameters other than V˙O2peak that might have prognostic value. We aimed at determining whether exercise recovery data kinetics have prognostic implications over V˙O2peak and Heart Failure Survival Score.

Methods: Exercise data from 200 consecutive CHF patients evaluated for possible heart transplantation and received CPET at our institution between 2004 and 2011 were analyzed. The rate of recovery of oxygen uptake (V˙O2) at 2 minutes after exercise (V˙O2-REC2) was calculated using the difference between V˙O2peak and V˙O2 at minute 2 of recovery and expressed as a percentage of V˙O2peak. The composite primary end point was the time from CPET to the first event including death, heart transplant, or mechanical heart implantation.

Results: Mean follow-up period was 1271 ± 61 days during which there were 108 first events including 35 deaths, 66 heart transplants, and 7 mechanical heart implantations. The strongest prognostic factors in the univariate analysis were V˙O2-REC2, V˙O2peak, V˙O2 efficiency slope, and ventilation to carbon dioxide excretion ratio slope (all P < 0.0001). Multivariate analysis showed that V˙O2-REC2 (P < 0.0001), ventilation to carbon dioxide excretion ratio slope (P = 0.0022), use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (P = 0.0042), presence of a defibrillator (P = 0.0127), and mean arterial pressure (P = 0.0151) were independent predictors of event-free survival time.

Conclusions: V˙O2-REC2 was the strongest prognostic marker of death, heart transplantation, and mechanical heart implantation in severe CHF. This finding should be confirmed prospectively.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Canada / epidemiology
  • Chronic Disease
  • Exercise Test* / adverse effects
  • Exercise Test* / methods
  • Female
  • Heart Failure* / diagnosis
  • Heart Failure* / metabolism
  • Heart Failure* / mortality
  • Heart Failure* / therapy
  • Heart Transplantation / methods
  • Heart-Assist Devices / statistics & numerical data
  • Humans
  • Male
  • Middle Aged
  • Oxygen Consumption / physiology
  • Oxygen* / metabolism
  • Oxygen* / pharmacokinetics
  • Predictive Value of Tests
  • Preoperative Care / methods
  • Prognosis
  • Recovery of Function / physiology*
  • Retrospective Studies
  • Survival Analysis
  • Time Factors

Substances

  • Oxygen